4553.T
4553.T
JP3623150004
TOWA PHARMACEUTICAL CO
Loading chart...

Company Profile

Towa Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sale ethical drugs in Japan. The company operates through two segments; Domestic and Overseas. It provides its products in the therapeutic areas of digestive system, nervous system, and allergic diseases, as well as vitamins, antibiotics, and oncology products, as well as provide formulations from tablets, capsules, injectable, patches, eye drops, and other products. The company also offers IT service related to healthcare; disease risk testing services; and sale of quasi drugs. In addition, it is involved in research and development and production of active pharmaceutical ingredients, intermediates, and support business; and planning, development and OEM manufacturing of health foods, pharmaceuticals, general foods, and other miscellaneous merchandizes. Towa Pharmaceutical Co., Ltd. was founded in 1951 and is headquartered in Kadoma, Japan.

Related stocks

4887.T
4887.T • Japan
SAWAI GROUP HOLDINGS CO LTD
1,629.5 JPY
1.19B USD 1Y -18.6%
4516.T
4516.T • Japan
NIPPON SHINYAKU CO
3,372 JPY
1.44B USD 1Y -0.4%
4547.T
4547.T • Japan
KISSEI PHARMACEUTICAL CO
3,710 JPY
981.04M USD 1Y -13.4%
4540.T
4540.T • Japan
TSUMURA & CO
3,772 JPY
1.78B USD 1Y +5%
4534.T
4534.T • Japan
MOCHIDA PHARMACEUTICAL CO
3,075 JPY
682.51M USD 1Y -1.6%
4559.T
4559.T • Japan
ZERIA PHARMACEUTICAL
1,925 JPY
536.21M USD 1Y -4.4%
600488.SS
600488.SS • China
TIANJIN TIANYAO PHARMACEUTICAL
6.47 CNY
1.06B USD 1Y +59%
002550.SZ
002550.SZ • China
QIANHONG BIO-PHARMA
6.52 CNY
1.25B USD 1Y -28.4%

Key Metrics & Overview

Detailed metrics & financial data of the company

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
33.2% p.a.
Max Drawdown (5Y)
-51.6%
Sharpe Ratio (5Y)
-0.03
Beta Factor
-0.04
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Structurally High Volatility: Above-average fluctuations persist across 5 to 10 years (33.2% p.a.).
Historical Stress Test: Maximum peak-to-trough drawdown of -51.6% in the extended horizon.
ende